RT @Yuz6Yusof: #POS0263 #EULAR2022 In #rituximab-treated RMD patients with undetectable humoral response to primary #COV
Tweet Content
#POS0263 #EULAR2022 In #rituximab-treated RMD patients with undetectable humoral response to primary #COVID 💉, a study (N=84) found Re-Vaccination with mRNA (2 shots) was better than a Booster (1 shot). Lend support for current approach: 2 + 3rd Primary + Booster @RheumNow https://t.co/AH0wpVKbHc
Show on Archive Page
On
Display in Search Results
On
PDQ
Off